Roivant Sciences LTD. income statement & cash flow

Ticker ROIV · SEC CIK 1635088 · Latest fiscal year ended Mar 31, 2026

In the fiscal year ended Mar 31, 2026, Roivant Sciences LTD. reported net income of −$299.77M on revenue of $8.26M. Operating cash flow was −$750.35M and capital expenditures were $8.21M, leaving −$758.56M of free cash flow (operating cash flow minus capital expenditures).

Roivant Sciences LTD. net income by fiscal year, USD. Hover a bar for the exact figure.

Income statement and cash flow summary

Fiscal year ended	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue (USD)	$23.80M	$55.29M	$31.53M	$32.71M	$29.05M	$8.26M
Operating income (USD)	−$1.07B	−$1.35B	−$906.76M	$4.50B	−$1.00B	−$515.07M
Net income (USD)	−$809.23M	−$845.26M	−$1.01B	$4.35B	−$171.98M	−$299.77M
Diluted EPS (USD per share)	—	−$1.26	−$1.42	$5.23	−$0.24	−$0.54
Operating cash flow (USD)	−$552.14M	−$677.73M	−$843.39M	−$765.27M	−$839.45M	−$750.35M
Capital expenditures (USD)	$5.81M	$17.44M	$12.69M	$1.38M	$4.60M	$8.21M
Reported in	10-K 2022	10-K 2023	10-K 2025	10-K 2026	10-K 2026	10-K 2026

Columns are fiscal years, labeled by the month the year ended; scroll sideways on small screens. — means the company did not report the figure under the XBRL concepts we track.

Margins

Each figure divided by revenue for the same fiscal year.

Fiscal year ended	Gross margin	Operating margin	Net margin
Mar 2026	—	-6235.7%	-3629.2%
Mar 2025	—	-3453.3%	-592.0%
Mar 2024	—	13746.9%	13294.2%
Mar 2023	—	-2875.9%	-3200.2%
Mar 2022	—	-2444.8%	-1528.9%

Roivant Sciences LTD. operating cash flow by fiscal year, USD. Hover a bar for the exact figure.

Source: SEC EDGAR XBRL company facts for CIK 1635088 (raw data). Most recent filing in this dataset: 10-Q filed Aug 6, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.